Integer (NYSE:ITGR) Releases FY 2026 Earnings Guidance

Integer (NYSE:ITGR) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 6.290-6.780 for the period, compared to the consensus EPS estimate of 6.310. The company issued revenue guidance of $1.8 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ITGR. Wells Fargo & Company restated an “equal weight” rating and issued a $80.00 target price (down previously from $132.00) on shares of Integer in a report on Friday, October 24th. Argus cut shares of Integer from a “buy” rating to a “hold” rating in a research report on Friday, October 24th. Piper Sandler dropped their target price on shares of Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a report on Friday, October 24th. Wall Street Zen cut Integer from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Finally, Truist Financial lifted their price objective on Integer from $86.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday, December 18th. Four investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Integer has an average rating of “Hold” and an average target price of $98.38.

Integer Stock Performance

Shares of ITGR stock traded down $1.45 during trading hours on Thursday, reaching $85.03. The company had a trading volume of 1,252,331 shares, compared to its average volume of 760,797. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71. The business has a fifty day moving average price of $82.37 and a 200-day moving average price of $88.44. Integer has a one year low of $62.00 and a one year high of $144.76. The firm has a market cap of $2.98 billion, a PE ratio of 35.58, a price-to-earnings-growth ratio of 0.81 and a beta of 0.77.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, February 19th. The medical equipment provider reported $1.76 EPS for the quarter, beating analysts’ consensus estimates of $1.70 by $0.06. Integer had a return on equity of 12.84% and a net margin of 4.75%.The company had revenue of $472.06 million during the quarter, compared to analysts’ expectations of $462.73 million. During the same quarter in the prior year, the business earned $1.43 earnings per share. Integer’s revenue for the quarter was up 5.0% compared to the same quarter last year. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. Sell-side analysts predict that Integer will post 6.01 earnings per share for the current fiscal year.

Integer declared that its board has approved a stock repurchase program on Tuesday, November 4th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the medical equipment provider to buy up to 8.3% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board believes its shares are undervalued.

Key Integer News

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Q4 beat — Integer reported EPS of $1.76 vs. the $1.70 consensus and revenue of $472.1M vs. $462.7M, with revenue up ~5% year-over-year. The print shows near-term operational momentum. Integer (ITGR) Surpasses Q4 Earnings and Revenue Estimates
• Positive Sentiment: Full‑year performance and FY26 outlook — Integer delivered ~8% sales growth and ~21% adjusted EPS growth for FY2025 and maintained its October outlook (midpoint of sales growth; high end of adjusted EPS growth). Management still expects above‑market organic growth into 2027. Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025
• Neutral Sentiment: FY‑2026 guidance roughly in line with expectations — Company set EPS guidance of $6.290–$6.780 (Street ~6.31) and revenue range of ~$1.8B–$1.9B (Street ~$1.8B). Guidance implies steady growth but is not a clear upside surprise. Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025
• Neutral Sentiment: Investor materials and color — Company posted the press release, slide deck and a conference‑call transcript/slides for those who want details on margin drivers and segment trends. These materials will guide near‑term analyst revisions. Quarterly press release & slide deck
• Negative Sentiment: Market reaction/valuation and technicals — Despite the beats, the stock traded lower today; potential reasons include guidance that was largely in line with expectations (so no clear upside), profit‑taking after prior gains, and elevated valuation/technicals (current price below the 200‑day moving average and a relatively high P/E). Higher trading volume suggests active repositioning. Integer stock overview (MarketBeat)

Institutional Trading of Integer

Several hedge funds have recently modified their holdings of ITGR. Parkside Financial Bank & Trust raised its stake in shares of Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 267 shares in the last quarter. Arax Advisory Partners grew its holdings in Integer by 2,489.5% in the fourth quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 473 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Integer by 210.5% during the second quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock worth $66,000 after purchasing an additional 362 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Integer by 861.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 692 shares of the medical equipment provider’s stock valued at $85,000 after purchasing an additional 620 shares during the last quarter. Finally, Van ECK Associates Corp lifted its holdings in shares of Integer by 31.8% during the 3rd quarter. Van ECK Associates Corp now owns 1,427 shares of the medical equipment provider’s stock valued at $147,000 after purchasing an additional 344 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.